Steven Charlap

Steven Charlap’s healthcare career spans over 30 years and has taken him in several directions. Trained as a surgeon, and armed with an MBA, he was initially recruited to become Director of Corporate Development for T-Cell Sciences (TCS), a publicly traded biotechnology company, at which he oversaw technology licensing and pharmaceutical partnerships. In 1989, Steven left TCS to co-found, as CEO and Chief Medical Officer, HealthDrive Corporation, the largest U.S. provider of medical and dental services to extended care facilities. Over twenty years, a two-time Inc. 500 company, HealthDrive served more than five million patients in some 1,500 facilities across 13 states. At HealthDrive, he built the first multi-specialty mobile electronic medical record system. In 2000, he published Making Sense of Nursing Homes—A Guide for Families.

During his HealthDrive tenure, Steven witnessed how the health care industry’s non-focus on preventing chronic diseases often results in costly, invasive and reactive medical treatment for patients. In response, he developed the concept of MDPrevent—a multi-disciplinary, integrated primary care and preventive medicine practice focused on helping patients make lasting lifestyle changes to achieve exceptional lives.

While at Stanford, Dr. Charlap focused on genetics, genomics, and preventive medicine as well as consumer behavior, problem solving, and health care and media technology. He also consulted with dozens of genetics/genomics and computer science experts both at Stanford and across the country, and mentored over two-hundred entrepreneurs. In 2017, he received a Stanford SPADA grant to further develop VALIDATE, Virtual Agent Linked Intelligent Disease Assessment Tool Engine.

He is currently a Visiting Scientist at Harvard and CEO of GeneYes, a digital health care startup applying AI-driven Virtual Health Assistants to improve comprehensive health care data collection, analysis, and reporting for various applications, e.g. cancer predisposition assessment, nutritional intake assessment, etc. He is collaborating with Harvard in planning a pilot study of VALIDATE.

Steven Charlap received a BA from Yeshiva University, where he majored and minored in Speech & Drama and Film, respectively, an MD from New York University School of Medicine, and an MBA from Harvard Business School, where he majored in entrepreneurship.

Buttontwitter Buttonlinkedin
This website uses cookies to ensure you get the best experience. Learn more